表紙:便秘症向け機能性食品の世界市場(2021年~2027年)
市場調査レポート
商品コード
1064695

便秘症向け機能性食品の世界市場(2021年~2027年)

Constipation Nutraceuticals Market 2021-2027

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 125 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=137.14円
便秘症向け機能性食品の世界市場(2021年~2027年)
出版日: 2022年01月29日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文 125 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の便秘症向け機能性食品の市場規模は、予測期間中にかなりのCAGRで成長すると予測されています。当市場を牽引する主な要因には、高齢者人口の増加と食生活の変化、IBS-C、OIC、慢性便秘の高い有病率、最新の薬剤や治療手順の開発などがあります。また、薬剤の入手が可能であることから、消費、ひいては便秘症向け機能性食品市場を後押しすると予想されます。

当レポートでは便秘症向け機能性食品市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、タイプ別、形態別、地域別の市場分析、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向

第3章 市場の決定要因

  • 促進要因
  • 抑制要因
  • 市場機会

第4章 市場細分化

  • 世界の便秘症向け機能性食品市場:タイプ別
    • プレバイオティクスとプロバイオティクス
    • 繊維と特殊炭水化物
    • ビタミンとミネラル
    • アミノ酸とタンパク質
    • オメガ3脂肪酸
    • カロテノイド
  • 世界の便秘症向け機能性食品市場:形態別
    • 乾燥
    • 液体

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • その他アジア太平洋地域
  • その他の地域

第6章 企業プロファイル

  • Abbott Laboratories
  • Ajinomoto Group
  • DSM N.V
  • DuPont de Nemours, Inc
  • Glanbia plc
  • GlaxoSmithKline plc.
  • Ingredion Incorporated
  • Kerry Group
  • Kraft Heinz Company
  • Tate & Lyle
図表

LIST OF TABLES

  • 1. GLOBAL CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 2. GLOBAL PREBIOTICS & PROBIOTICS IN CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL FIBERS & SPECIALTY CARBOHYDRATES IN CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL VITAMINS & MINERALS IN CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL AMINO ACIDS & PROTEINS IN CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL OMEGA-3 FATTY ACIDS IN CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL CAROTENOIDS IN CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY FORM 2020-2027 ($ MILLION)
  • 9. GLOBAL DRY CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL LIQUID CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. NORTH AMERICAN CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 12. NORTH AMERICAN CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 13. NORTH AMERICAN CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY FORM2020-2027 ($ MILLION)
  • 14. EUROPEAN CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 15. EUROPEAN CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 16. EUROPEAN CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY FORM 2020-2027 ($ MILLION)
  • 17. ASIA-PACIFIC CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 18. ASIA-PACIFIC CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 19. ASIA-PACIFIC CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY FORM2020-2027 ($ MILLION)
  • 20. REST OF THE WORLD CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 21. REST OF THE WORLD CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY TYPE2020-2027 ($ MILLION)
  • 22. REST OF THE WORLD CONSTIPATION NUTRACEUTICALS MARKET RESEARCH AND ANALYSIS BY FORM, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CONSTIPATION NUTRACEUTICALS MARKET SHARE BY TYPE, 2020 VS 2027 (%)
  • 2. GLOBAL CONSTIPATION NUTRACEUTICALS MARKET SHARE BYFORM2020 VS 2027 (%)
  • 3. GLOBAL CONSTIPATION NUTRACEUTICALS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 4. US CONSTIPATION NUTRACEUTICALS MARKET SIZE, 2020-2027 ($ MILLION)
  • 5. CANADA CONSTIPATION NUTRACEUTICALS MARKET SIZE, 2020-2027 ($ MILLION)
  • 6. UK CONSTIPATION NUTRACEUTICALS MARKET SIZE, 2020-2027 ($ MILLION)
  • 7. FRANCE CONSTIPATION NUTRACEUTICALS MARKET SIZE, 2020-2027 ($ MILLION)
  • 8. GERMANY CONSTIPATION NUTRACEUTICALS MARKET SIZE, 2020-2027 ($ MILLION)
  • 9. ITALY CONSTIPATION NUTRACEUTICALS MARKET SIZE, 2020-2027 ($ MILLION)
  • 10. SPAIN CONSTIPATION NUTRACEUTICALS MARKET SIZE, 2020-2027 ($ MILLION)
  • 11. REST OF EUROPE CONSTIPATION NUTRACEUTICALS MARKET SIZE, 2020-2027 ($ MILLION)
  • 12. INDIA CONSTIPATION NUTRACEUTICALS MARKET SIZE, 2020-2027 ($ MILLION)
  • 13. CHINA CONSTIPATION NUTRACEUTICALS MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. JAPAN CONSTIPATION NUTRACEUTICALS MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC CONSTIPATION NUTRACEUTICALS MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. REST OF THE WORLD CONSTIPATION NUTRACEUTICALS MARKET SIZE, 2020-2027 ($ MILLION)
目次
Product Code: OMR2024180

Global Constipation Nutraceuticals Market Size, Share & Trends Analysis Report, By Type (Prebiotics & Probiotics, Fibers & Specialty Carbohydrates, Vitamins & Minerals, Amino Acids & Proteins, Omega-3 Fatty Acids, and Carotenoids), By Form (Dry and Liquid)Forecast (2021-2027)

The global constipation nutraceuticals market is anticipated to grow at a considerable CAGR during the forecast period. The increasing geriatric population and changing dietary habits, high prevalence of IBS-C, OIC, and chronic constipation, and the development of the latest drugs and treatment procedures are the prominent factors for the market growth. Irritable bowel syndrome (IBS) is found affecting up to 7%-18% of the population worldwide and therefore its prevalence is increasing that is driving the demand for constipation nutraceuticals. In addition, the availability of drugs is expected to boost consumption, and hence the constipation nutraceuticals market.

The global constipation nutraceuticals market is segmented based on type and form. Based on type, the market is sub-segmented into prebiotics & probiotics, fibers & specialty carbohydrates, vitamins & minerals, amino acids & proteins, omega-3 fatty acids, and carotenoids. On the basis of form, the market is sub-segmented into dry and liquid.

Geographically, the global constipation nutraceuticals market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World.

Some of the companies operating in the global constipation nutraceuticals market include DuPont de Nemours, Inc., Glanbia plc, Associated British Foods, Plc, Ajinomoto Group, BASF SE, Kerry Group, and Others.

Market Segmentation

1. Global Constipation Nutraceuticals Market Research and Analysis by Type

2. Global Constipation Nutraceuticals Market Research and Analysis by Form

The Report Covers

  • Comprehensive research methodology of the global constipation nutraceuticals market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global constipation nutraceuticals market.
  • Insights about market determinants that are stimulating the global constipation nutraceuticals market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Market Determinants

  • 3.1. Motivators
  • 3.2. Restraints
  • 3.3. Opportunities

4. Market Segmentation

  • 4.1. Global Constipation Nutraceuticals Market by Type
    • 4.1.1. Prebiotics & Probiotics
    • 4.1.2. Fibers & Specialty Carbohydrates
    • 4.1.3. Vitamins & Minerals
    • 4.1.4. Amino Acids & Proteins
    • 4.1.5. Omega-3 Fatty Acids
    • 4.1.6. Carotenoids
  • 4.2. Global Constipation Nutraceuticals Market by Form
    • 4.2.1. Dry
    • 4.2.2. Liquid

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Abbott Laboratories
  • 6.2. Ajinomoto Group
  • 6.3. DSM N.V
  • 6.4. DuPont de Nemours, Inc
  • 6.5. Glanbia plc
  • 6.6. GlaxoSmithKline plc.
  • 6.7. Ingredion Incorporated
  • 6.8. Kerry Group
  • 6.9. Kraft Heinz Company
  • 6.10. Tate & Lyle